Drug-induced endoplasmic reticulum and oxidative stress responses independently sensitize toward TNFα-mediated

Lisa Fredriksson1, Steven Wink1, Bram Herpers1

  • 1Division of Toxicology, Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden The Netherlands.

Insights

Drug-induced liver injury involves synergistic pathways. Tumor necrosis factor α (TNFα) combined with endoplasmic reticulum (ER) stress, specifically PERK/CHOP signaling, drives liver cell death, independent of Nrf2 antioxidant responses.

Area of Science:

  • Hepatology
  • Toxicology
  • Molecular Biology

Background:

  • Drug-induced liver injury (DILI) is a significant clinical challenge.
  • Understanding the molecular mechanisms of DILI is crucial for developing effective treatments.
  • Tumor necrosis factor α (TNFα) is implicated in inflammatory responses that can contribute to liver injury.

Purpose of the Study:

  • To investigate the synergistic role of drug-induced toxicity pathways and TNFα in liver cell death.
  • To identify key signaling pathways involved in DILI using a genomics approach.
  • To elucidate the interplay between endoplasmic reticulum (ER) stress, antioxidant signaling, and TNFα in hepatotoxicity.

Main Methods:

  • Genomics and transcriptomics analysis of HepG2 cells and primary human hepatocytes exposed to hepatotoxicants (diclofenac, carbamazepine).
  • Investigated the involvement of ER stress (PERK, ATF4, CHOP, IRE1α, ATF6) and Nrf2 antioxidant signaling pathways.
  • Utilized targeted RNA interference and assessed the impact of TNFα synergism.

Main Results:

  • Diclofenac and carbamazepine induced ER stress and Nrf2 signaling, mirroring responses to other DILI compounds.
  • Activation of PERK/ATF4/CHOP signaling was critical for drug/TNFα-induced apoptosis, independent of TNFα.
  • Cytoprotective ER stress pathways (IRE1α, ATF6) and Nrf2 signaling did not influence CHOP expression.
  • Enhanced translational initiation factor EIF4A1 was essential for CHOP expression and drug/TNFα-mediated liver cell death.

Conclusions:

  • Drug-induced translation, via EIF4A1, initiates PERK-mediated CHOP signaling, sensitizing liver cells to TNFα-induced apoptosis.
  • The interplay between ER stress, specifically PERK/CHOP, and TNFα is a key mechanism in DILI.
  • Targeting EIF4A1 or the PERK/CHOP pathway may offer novel therapeutic strategies for DILI.

Related Concept Videos

Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
229
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
209
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
151
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
220
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.2K
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
229